Skip to content
Search

Latest Stories

PDA defends 'right to strike' against proposed legislation of 'anti-strike'

In response to Thursday (5 January)’s announcement on the proposal of new ‘anti-strike’ legislation, the Pharmacists Defence Association (PDA) has said that it will work with other trade unions to defend the fundamental right for workers in the sector to strike.

The association believes that “industrial action should always be a last resort, especially for health professionals such as pharmacists, however having the option to strike is a fundamental right for working people in a fair and free, civilised society.”


“The right to strike is a fundamental right through which employees can act collectively to secure and protect pay and conditions.”

It added: “The Trade Union Congress (TUC) are coordinating the challenge to these proposals.”

The TUC said in a statement: “The Prime Minister should concentrate on fixing our public services, not attacking public sector staff. The proposed legislation would make it harder for disputes to be resolved.”

TUC General Secretary Paul Nowak said: “The announcement offers nothing more to help with this year’s pay and the cost of living crisis. The only offer of talks is for next year. But we need to resolve the current disputes and boost the pay of public sector workers now.

“The Prime Minister should take up my offer to get around the table to improve this year’s pay and end the current disputes.

“Our public services are already deep in a staffing crisis. But this government has gone from clapping key workers to threatening them with the sack if they take lawful action for a pay rise. It will only push more people away from essential jobs in public services, harming the whole nation.”

TUC has invited every worker – public and private sector, and everyone who wants to be a part of their campaign to defend the right to strike.

More For You

Walgreens Boots Alliance acquired by Sycamore in deal

Walgreens Boots Alliancehas entered into “a definitive agreement” to be acquired by Sycamore Partners

Gettyimages

Walgreens Boots Alliance acquired by Sycamore in £18.3 billion deal

Walgreens Boots Alliance(WBA) has entered into “a definitive agreement” to be acquired by Sycamore Partners, a private equity firm specializing in retail, consumer and distribution-related investments.

“The total value of the transaction represents up to $23.7 billion (£18.3 billion),” the company announced late last night (6).

Keep ReadingShow less
Professor Sir Stephen Powis at a press briefing

Professor Sir Stephen Powis, was appointed national medical director of NHS England in 2018

NHS

NHS England’s top doctor to step down following Amanda Pritchard’s resignation

Just a week after NHS England chief executive Amanda Pritchard announced her resignation, the organisation’s national medical director, Professor Sir Stephen Powis, has confirmed he will step down this summer after more than seven years in the role.

In a statement released on Thursday, Professor Powis revealed that he had informed Pritchard of his intention to leave in a letter back in January.

Keep ReadingShow less
PDA calls on GP practices to use funding boost to improve job security for pharmacists

Now, it is time to focus on the community pharmacy contract

gettyimages

PDA urges GP practices to ensure funding boost supports employed pharmacists

The Pharmacists' Defence Association (PDA) has called on GP practicesto ensure that all healthcare professionals they employ, including pharmacists, benefit from the 7.2% funding boost they received under a newly agreed contract.

GP employers are encouraged to improve “job security, pay and conditions” for employees with this increased funding.

Keep ReadingShow less
Fourth Shift: Investment in Innovative Medicines Crucial for NHS 10-Year Plan Success

Medicines should be viewed as an investment rather than a cost

gettyimages

ABPI wants to see a ‘fourth shift’ in NHS 10-Year Health Plan


The Association of the British Pharmaceutical Industry (ABPI) has called on the government to increase investment in innovative medicines and vaccines, describing it as a crucial “fourth shift” necessary to ensure the NHS is fit for the future.

Keep ReadingShow less
Lawrence Tallon named new MHRA chief executive

Lawrence Tallon

Photo credit: Sciana Network

Lawrence Tallon named new MHRA chief executive

Lawrence Tallon has been appointed as the new chief executive officer of the Medicines and Healthcare products Regulatory Agency (MHRA), effective 1 April 2025.

He will succeed Dame June Raine DBE, who is retiring after leading the agency since 2019.

Keep ReadingShow less